Recent Developments in Thyroid Eye Disease
BMJ 329:385-390, Cawood,T.,et al, 2004
Dysthyroid Orbitopathy
Semin Neurol 20:43-54, Jacobson,D.M., 2000
Vertical Diplopia
Semin Neurol 20:21-30, Acierno,M.D., 2000
Radiotherapy for Graves' Orbitopathy: Randomised Placebo-Controlled Study
Lancet 355:1505-1509, Mourits,M.P.,et al, 2000
Binocular Vertical Diplopia
Mayo Clin Proc 73:55-66, Brazis,P.W.&Lee,A.G., 1998
Relation Between Therapy for Hyperthyroidism and the Course of Graves'Ophthalmopathy
NEJM 338:73-78, 1211998., Bartalena,L.,et al, 1998
Extreme Eyelid Swelling as an Unusual Presentation of Dysthyroid Orbitopathy
J Neuro-Ophthalmol 15:84-89, Rosen,C.E.&Kennerdell,J.S., 1995
Acetylcholine Receptor Antibodies in Patients with Graves'Ophthalmopathy
J Neuro-Ophthalmol 15:166-170, Jacobson,D.M., 1995
Extraocular Muscles in Graves Ophthalmopathy:Usefulness of T2 Relaxation Time Measurements
Radiology 190:857-862, Ohnishi,T.,et al, 1994
Expression of Thyrotropin-Receptor mRNA in Healthy and Graves'Disease Retro-Orbital Tissue
Lancet 342:337-338, 3181993., Feliciello,A.,et al, 1993
Pathogenesis of Graves'Ophthalmopathy
NEJM 329:1468-1475, Bahn,R.S.&Heufelder,A.E., 1993
Randomised Double-Blind Trial of Prednisone vs. Radiotherapy in Graves'Ophthalmopathy
Lancet 342:949-954, Prummel,M.F.,et al, 1993
Octreotide and Graves'Ophthalmopathy and Pretibial Myxoedema
BMJ 304:158, Chang,T.C.,et al, 1992
Occurrence of Ophthalmopathy after Treatment for Graves'Hyperthyroidism
NEJM 326:1733-1738, 17721992., Tallstedt,L.,et al, 1992
Thyroid-Associated Eye Disease:Pathophysiology
Lancet 338:25-28, Weetman,A.P., 1991
Thyroid-Associated Eye Disease:Clinical Management
Lancet 338:29-32, Fells,P., 1991
Graves'Ophthalmopathy
BMJ 300:1352-1353, Fleck,B.W.&Toft,A.D., 1990
Graves Orbitopathy:Correlation of CT and Clinical Findings
Radiology 177:675-682, Nugent,R.A.,et al, 1990
Use of Corticosteroids to Prevent Progression of Radioiodine Therapy for Hyperthyroidism
NEJM 321:1349-1352, 14031989., Bartalena,L.,et al, 1989
Prednisone and Cyclosporine in the Treatment of Severe Graves'Ophthalmopathy
NEJM 321:1353-1359, 14031989., Prummel,M.F.,et al, 1989
Graves Ophthalmopathy:MR Imaging of the Orbits
Radiology 172:759-762, Hosten,N.,et al, 1989
Computed Tomographic Features of Nonthyroid Extraocular Muscle Enlargement
Ophthalmol 96:1038-1047, Patrinely,J.R.,et al, 1989
Intravenous Methylprednisolone in the Treatment of Graves'Ophthalmopathy
BMJ 297:1574-1578, Kendall-Taylor,P.,et al, 1988
Minimal Thyroid Ophthalmopathy
Neurol 37:1803-1808, Spector,R.H.&Carlisle,J.A., 1987
Measurement of Autoantibodies Against Human Eye Muscle Plasma Membranes in Graves'Ophthalmopathy
BMJ 290:191-192, Faryna,M.,et al, 1985
Lacrimal Gland Enlargement
In Latchaw R. E. Computed Tomography of the Head, Neck & Spine, Year Book Med Publ, Chicago 401, Rothfus,W.E., 1985
Dysthyroid Orbitopathy
Neurol 35:1628-1634, Dresner,S.C.&Kennerdell,J.S., 1985
Clinical Decisions in Neuro-Ophthalmology
CV Mosby:154-156, Burde,R.M.,et al, 1985
A Specific IgG in Graves'Ophthalmopathy & Its Relation to Retro-Orbital & Thyroid Autoimmunity
BMJ 288:1183-1186, Kendall-Taylor,P.,et al, 1984
Graves'Disease Presenting with Bilateral Acute Painful Proptosis, Ptosis, Ophthalmoplegia, & Visual Loss
Lancet 2:431-433, Leonard,T.J.K.,et al, 1984
Correlation of CT Scanning and Pathologic Features of Ophthalmic Graves'Disease
Ophthalmol 88:553-564, Trokel,S.L.&Jakobiec,F.A., 1981
Dysthyroid & Myasthenic Myopathy of the Medial Rectus:A Clinical Pathologic Report
Neurol 30:939-944, Spoor,T.C.,et al, 1980
Medical Approach to Ophthalmopathy of Graves'Disease
Mayo Clin Proc 47:980, Ivy,H., 1972
Eye Changes of Graves s Disease
Mayo Clin Proc 47:969, Werner,S., 1972
Recent Advances in the Therapy of Thyroid Eye Disease
In Neuroophthalmology, C V Mosby Co, St. Louis, 6:1-102., Smith,J.L., 1972
Thyrotoxic Periodic Paralysis
UptoDate Jan, Gutmann, L. & Conwit, R., 2022
A Teenager with Persistent Headache
Neurol 92:e1526-e1531, Hu, Y.,et al, 2019
Abdominal Tremor in Thyrotoxicosis
Neurol 89:1424-1425, Kelly, D.M.,et al, 2017
Clincopathologic Conference,Graves Disease with Thyrotoxic Periodic Paralysis
NEJM 366:553-560, Case 4-2012, 2012
Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011
Hyperthyroidism and Risk of Ischemic Stroke in Young Adults: A 5-Year Follow-Up Study
Stroke 41:961-966, Sheu,J.-J., et al, 2010
Plasma Exchange for Anti GAD Associated Non Paraneoplastic Limbic Encephalitis
Transfus Apher Sci 39:229-233, Mazzi,G.,et al, 2008
Woke Up Paralysed--Without Injury or Stroke
Lancet 371:870, Bawaskar,H.S. &Bawaskar,P.H., 2008
Protein S Deficiency in HIV Associated Ischaemic Stroke:An Epiphenomenon of HIV Infection
JNNP 76:1455-1456,1331, Mochan,A.,et al, 2005
Bilateral Carotid Artery Dissection With Thyrotoxicosis
Neurol 63:2443-2444, Campos,C.R.,et al, 2004
Clinical Spectrum of Chronic Acquired Demyelinating Polyneuropathies
Muscle & Nerve 24:311-324, Saperstein,D.S.,et al, 2001
Use of Specialized Coagulation Testing in the Evaluation of Patients with Acute Ischemic Stroke
Neurol 56:624-627, Bushnell,C.,et al, 2001
Neuromuscular Findings in Thyroid Dysfunction: A Prospective Clinical and Electrodiagnostic Study
JNNP 68:750-755, Duyff,R.F. et al, 2000
Prethrombotic Disorders in Children with Arterial Ischemic Stroke and Sinovenous Thrombosis
Arch Neurol 56:967-971, Bonduel,M.,et al, 1999